tradingkey.logo
tradingkey.logo
Suchen

Retractable Technologies Inc

RVP
Zur Watchlist hinzufügen
0.729USD
+0.009+1.19%
Handelsschluss 07/01, 16:00ETKurse um 15 Minuten verzögert
21.81MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Retractable Technologies Inc Unternehmen

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Retractable Technologies Inc Informationen

BörsenkürzelRVP
Name des UnternehmensRetractable Technologies Inc
IPO-datumMay 04, 2001
CEOShaw (Thomas J)
Anzahl der mitarbeiter221
WertpapierartOrdinary Share
GeschäftsjahresendeMay 04
Addresse511 Lobo Lane
StadtLITTLE ELM
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl75068-0009
Telefon19722941010
Websitehttps://retractable.com/
BörsenkürzelRVP
IPO-datumMay 04, 2001
CEOShaw (Thomas J)

Führungskräfte von Retractable Technologies Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.66M
+1.99%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.66M
+1.99%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Retractable Technologies Inc?

Die fünf größten Anteilseigner von Retractable Technologies Inc sind: Mr. Thomas J. Shaw

Wie viele Institutionen halten Anteile an Retractable Technologies Inc (RVP)?

Mit Stand vom 2026Q1 halten 62 Institutionen Anteile an Retractable Technologies Inc, mit einem Gesamtmarktwert von etwa 3.30M, was 11.01% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 627168.00 gestiegen.

Was ist die größte Einnahmequelle von Retractable Technologies Inc?

Am 2026Q1 erzielte das Geschäft mit Syringes für Retractable Technologies Inc den höchsten Umsatz in Höhe von 24.91M, was 65.10% des Gesamtumsatzes entspricht.